title: Treatment of massive gastrointestinal bleeding occurred during autologous stem cell transplantation with recombinant activated factor VII and octreotide.
abstract: After hematopoietic stem cell transplantation (HSCT), patients may suffer from bleeding. One of the bleeding type is gastrointestinal (GI) which has serious morbidity and mortality in children with limited treatment options. Herein, we presented a child with upper GI bleeding post autologous HSCT controlled successfully by using recombinant activated factor VII (rFVIIa) and octreotide infusion.
authors.affiliation: Department of Pediatric Oncology, Gulhane Military Medical Academy, Ankara, Turkey.
authors.forename: Erman
authors.initials: E
authors.lastname: Atas
authors.forename: Vural
authors.initials: V
authors.lastname: Kesik
authors.forename: Orhan
authors.initials: O
authors.lastname: Gürsel
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D064592:Autografts; D002648:Child; D003131:Combined Modality Therapy; D018240:Endodermal Sinus Tumor / Q000175:diagnosis* / Q000628:therapy; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use*
chemical_list: D015942:Factor VIIa; D015282:Octreotide